Joseph Allen

Joseph Allen

Joseph Allen is a Featured Contributor on IPWatchdog.com, and a 30-year veteran of national efforts to foster public/private sector commercialization partnerships, and author of numerous articles on technology management for national publications.

Joe served as a Professional Staff Member on the U.S. Senate Judiciary Committee with former Senator Birch Bayh (D-IN), and was instrumental in working behind the scenes to ensure passage of the historic Bayh-Dole Act. He is our resident Bayh-Dole expert, and will write frequently about Bayh-Dole and issues surrounding the commercialization of university research.

In 2008, Joe founded Allen & Associates, through which he offers consulting services assisting clients in technology transfer issues, including developing effective communication strategies with national policy makers.


Posts by Joseph Allen


Pity the Patients if Exclusive Licensing is Undermined

We've learned from experience that just because a theory's off base doesn't mean it won't take root, particularly when it involves patents and medicine. "No Vaccines Before …
By Joseph Allen
17 days ago 1

Think Twice Before Pulling the Plug on Tech Transfer

Most assaults on public/private sector R&D partnerships are launched by those who believe patents are inherently bad and that through some undefined magic publicly funded …
By Joseph Allen
2 months ago 0

Bernie Sander’s Really Bad Idea

Sen. Bernie Sanders (I-VT) introduced legislation requiring every agency and non-profit entity to include a "reasonable pricing" provision based on King's formula for any life science invention …
By Joseph Allen
3 months ago 14

Proposal from Senator King Won’t Reduce Drug Prices, Just Innovation

Many were stunned to learn that Senator Angus King (I-ME) included language undermining the Bayh-Dole Act in the report of the Senate Armed Services Committee as it …
By Joseph Allen
4 months ago 3

Academic Patent Licensing Helps Drive the U.S. Economy

What's even more impressive is the impacts on gross industry output and GDP are up 14% while  the number of U.S. jobs supported rose 12% since the previous …
By Joseph Allen
5 months ago 8

Why NIH/Industry Partnerships Matter: Ask an HIV patient

Those who believe that patents aren't important or that companies would undertake the rigors of commercial development with only non-exclusive licenses don't understand the realities facing innovators …
By Joseph Allen
5 months ago 1

Want to Revive the Economy? Restore the Patent System!

The old arguments that patents inhibit innovation, and non-exclusivity with compulsory licensing leads to a brave new world are now in vogue. We've stood at this fork …
By Joseph Allen
7 months ago 17

The Plight of the Public Sector Entrepreneur

Being an entrepreneur isn't easy. While it is a tough road for anyone, it's particularly tough if you're in the public sector and threatened by politicians... Rather, …
By Joseph Allen
8 months ago 1

Will the Trump Administration Be Pro Patent?

One of the many questions about the Trump Administration after its first month is how it views the U.S. patent system. I asked several experienced veterans …
By Joseph Allen
9 months ago 57

The National Cancer Institute Didn’t Deserve This Treatment From the New York Times

While those in the military are often thanked for their service, let's also thank researchers like Dr. Rosenberg and his colleagues who spend their lives trying to …
By Joseph Allen
11 months ago 2

Advice for the Trump Administration and New Congress: Protect Bayh-Dole and Restore the Patent System

Bayh-Dole is running on autopilot without Executive branch oversight and U.S. patents are no longer the world's gold standard. Without a course correction, we could be …
By Joseph Allen
12 months ago 3

Make American Innovation Great Again

It's a fundamental principal of economics that the secure ownership of personal property is essential for prosperity. Walk through any public park and see how seldomly people …
By Joseph Allen
1 year ago 6

Winning the Drug Development Debate

We create two new companies around academic inventions every day of the year. The critical role such companies play in drug development is clear. The successful integration …
By Joseph Allen
1 year ago 0

State Department, Universities Blast UN Attack on Patents

If the UN Secretary General and the members of his "High Level Panel on Access to Medicines" thought the State Department was bluffing when it warned against …
By Joseph Allen
1 year ago 3

UN Secretary General’s Panel on Access to Medicines Reports: Government Knows Best

Delayed for months beyond its expected issue date the Secretary General's High Level Panel on Access to Medicine's report emerged yesterday. Apparently the panelists scrambled to better …
By Joseph Allen
1 year ago 4